Insider · CIK 0001673991
P. Kent Hawryluk
ceopresidentofficerdirector
Files at MBX (MBX Biosciences, Inc.). First filing Feb 5, 2025, latest Mar 16, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
3 / 0
$1.3M bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MBX: MBX Biosciences, Inc.
MBXOct 9, 2026 · close 53.24
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 51Moderate | MBXbuy MBX Biosciences, Inc. | $526k 18,500 shares | +4% | +384% from low-35% from high | |
| 54Moderate | MBX Biosciences, Inc. | $273k 20,000 shares | +4% | +146% from low-41% from high | |
| 54Moderate | MBX Biosciences, Inc. | $535k 50,000 shares | +13% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | MBX MBX Biosciences, Inc. | POpen-market purchase Common Stockindirect: By Trust | +18,500 | $28.41 | $526k | 486,777 | Mar 16, 2026 |
| Feb 26, 2026 | MBX MBX Biosciences, Inc. | MOption exercise Common Stock | +28,768 | $16.00 | $460k | 728,274 | Feb 27, 2026 |
| Feb 26, 2026 | MBX MBX Biosciences, Inc. | MOption exercise Stock option (right to buy)derivative | -28,768 | $0.00 | $0 | 91,668 | Feb 27, 2026 |
| Feb 2, 2026 | MBX MBX Biosciences, Inc. | AGrant or award Common Stock | +35,250 | $0.00 | $0 | 699,506 | Feb 3, 2026 |
| Feb 2, 2026 | MBX MBX Biosciences, Inc. | AGrant or award Stock option (right to buy)derivative | +164,500 | $0.00 | $0 | 164,500 | Feb 3, 2026 |
| Oct 24, 2025 | MBX MBX Biosciences, Inc. | MOption exercise Common Stock | +182,859 | $3.25 | $594k | 664,256 | Oct 28, 2025 |
| Oct 24, 2025 | MBX MBX Biosciences, Inc. | MOption exercise Stock option (right to buy)derivative | -182,859 | $0.00 | $0 | 129,708 | Oct 28, 2025 |
| Oct 20, 2025 | MBX MBX Biosciences, Inc. | POpen-market purchase Common Stockindirect: By Trust | +20,000 | $13.64 | $273k | 468,277 | Oct 21, 2025 |
| Feb 4, 2025 | MBX MBX Biosciences, Inc. | POpen-market purchase Common Stockindirect: By Trust | +50,000 | $10.69 | $535k | 448,277 | Feb 5, 2025 |
| Feb 3, 2025 | MBX MBX Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +243,000 | $0.00 | $0 | 243,000 | Feb 5, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.